Kajian klinikal Glioma di Minnesota
13 kajian untuk Glioma sedang mencari peserta di lokasi di Minnesota.
Bandar di Minnesota
Teks kajian rasmi (Bahasa Inggeris)
Medication Combinations of Dasatinib, Quercetin, Fisetin, Temozolomide, LMP744, and Autologous TLPO Vaccine for the Treatment of Previously Treated Glioma With Residual Disease
- Mayo Clinic in Rochester, Rochester
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07025226A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
- Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
- University of Minnesota/Masonic Cancer Center, Minneapolis
Mengambil pesertaFasa 1/2
12 Months – 21 Years · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05099003SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- Mayo Clinic - Rochester, Rochester
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT05303519Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
- Children's Minnesota, Minneapolis
Mengambil pesertaFasa 1
Umur 1 hingga 25 · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT04485559Feasibility of Intra- and Post-operative Microdialysis During Neurosurgery for Central Nervous System Lesions
- Mayo Clinic in Rochester, Rochester
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 18 Ogo 2026 · NCT04047264A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
- Mayo Clinic in Rochester, Rochester
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 10 Ogo 2026 · NCT07074756A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- St. Luke's Hospital, Duluth
Mengambil pesertaFasa 2
Umur 8 ke atas · Semua jantina · Dikemas kini 27 Jul 2026 · NCT05503797Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
- Mayo Clinic in Rochester, Rochester
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 24 Jun 2026 · NCT07468136Treatment of Patients With Recurrent High-Grade Glioma With APG-157 and Bevacizumab
- Mayo Clinic, Rochester
Mengambil pesertaFasa 1/2
Umur 19 ke atas · Semua jantina · Dikemas kini 8 Jun 2026 · NCT06011109Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
- Mayo Clinic Cancer Center, Rochester
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Apr 2026 · NCT06810544Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
- Mayo Clinic in Rochester, Rochester
Mengambil pesertaFasa 1
Umur 18 hingga 75 · Semua jantina · Dikemas kini 24 Mac 2026 · NCT06482905Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
- Mayo Clinic in Rochester, Rochester
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Nov 2025 · NCT05717153CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults
- Children's Minnesota, Minneapolis
Mengambil pesertaFasa 1
Umur 2 hingga 25 · Semua jantina · Dikemas kini 12 Mac 2024 · NCT06305910Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.